The PTEN alterations are particularly common in various tumor types, including endometrial (36.67%), brain (30.47%), cervical (23.81%), thyroid (13.63%), sarcoma (10%), and HNSCC (7.69%), underscoring its broad relevance in tumorigenesis [10]. Here, PTEN is linked to sarcoma.